#New York #Securities Class Action #Faruqi & Faruqi #Medpace Holdings

Attention Medpace Investors: Important Legal Update

As investors in Medpace Holdings, Inc. (NASDAQ: MEDP) look toward a pivotal class action deadline, Faruqi & Faruqi, LLP, one of the premier national securities law firms, is stepping up to remind stakeholders of their legal rights. The firm is investigating potential claims against Medpace, particularly concerning events that transpired between April 22, 2025 and February 9, 2026. This administrative alert emphasizes the June 8, 2026 deadline to seek the lead plaintiff role in a federal securities class action lawsuit that has recently been filed against the company.

In the scope of the investigation, Faruqi & Faruqi partner James (Josh) Wilson encourages anyone who suffered financial losses due to the company’s actions to reach out for more information. Targeted investors who purchased or acquired Medpace securities during the specified time frame are urged to engage directly with the firm for legal guidance and to discuss their options.

The allegations at the heart of the complaint suggest that Medpace had delivered excessively positive statements to investors, all while hiding crucial negative information regarding the health of its backlog cancellation rates. According to the report, Medpace consistently presented its cancellation rates as